bn:02615279n
Noun Concept
JA
No term available
EN
Linifanib is a structurally novel, potent inhibitor of receptor tyrosine kinases, vascular endothelial growth factor and platelet-derived growth factor with IC50 of 0.2, 2, 4, and 7 nM for human endothelial cells, PDGF receptor beta, KDR, and colony stimulating factor 1 receptor, respectively. Wikipedia
Relations
Sources